Enhanced Recovery After Surgery (ERAS) for Ambulatory TURBT

Johns Hopkins University

Status: Completed

Conditions: Bladder Cancer

Treatments: Other: Standard of Care; Other: ERAS Protocol

Study type: Interventional

Funder types: Other

Identifiers

NCT05905276

IRB00392063

Details and patient eligibility

About

This is a single-center, randomized-controlled trial to investigate the effectiveness of an ERAS protocol compared to usual care in patients with bladder cancer undergoing ambulatory TURBT. The ERAS protocol is comprised of pre, intra and postoperative components designed to optimize each phase of perioperative care.

Enrollment: 100 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with suspected or known bladder cancer
• Age >= 18 years
• Undergoing initial or repeat TURBT
• Ambulatory TURBT with same day discharge home planned

Exclusion criteria

• Undergoing a planned concomitant procedure
• Inability to consent for themselves
• Unable to complete telephone-based follow up after discharge home
• Undergoing active treatment for muscle-invasive bladder cancer

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

100 participants in 2 patient groups

Standard of Care

Active Comparator group

Description:

Patients in the usual care arm of the trial will experience the present-day care pathway of ambulatory TURBT at Johns Hopkins Hospital.

Treatment:

Other: Standard of Care

ERAS Protocol

Experimental group

Description:

The ERAS protocol for ambulatory TURBT has been designed based on patient and provider input, a needs assessment of 150 patients in the hours after TURBT, a review of the literature, and experience with other ambulatory ERAS protocols already implemented at Johns Hopkins Hospital. The ERAS protocol for ambulatory TURBT aims to optimize care delivered in the pre, intra and postoperative settings.

Treatment:

Other: ERAS Protocol